These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36969231)

  • 1. The prognostic and immune significance of C15orf48 in pan-cancer and its relationship with proliferation and apoptosis of thyroid carcinoma.
    Li C; Tang Y; Li Q; Liu H; Ma X; He L; Shi H
    Front Immunol; 2023; 14():1131870. PubMed ID: 36969231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
    Zhang X; Meng X; Wang P; Luan C; Wang H
    Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
    Fei H; Han X; Wang Y; Li S
    Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Pan-Cancer Analysis and the Regulatory Mechanism of ASF1B, a Gene Associated With Thyroid Cancer Prognosis in the Tumor Micro-Environment.
    Ma J; Han W; Lu K
    Front Oncol; 2021; 11():711756. PubMed ID: 34490109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCDH8 is a novel prognostic biomarker in thyroid cancer and promotes cell proliferation and viability.
    Yang R; Yang N; Yin P; Xue Z; Sun F; Fan R; Liang J; Lv X; Wu S; Sun L
    Funct Integr Genomics; 2024 Feb; 24(2):35. PubMed ID: 38368303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
    Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
    BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAPN8 involves with exhausted, inflamed, and desert immune microenvironment to influence the metastasis of thyroid cancer.
    Zhong X; Xu S; Wang Q; Peng L; Wang F; He T; Liu C; Ni S; He Z
    Front Immunol; 2022; 13():1013049. PubMed ID: 36389799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer.
    Li C; Li Q; Li L; Sun S; Lei X
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):97. PubMed ID: 38538258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of prognostic biomarkers related to the tumor microenvironment in thyroid carcinoma.
    Du JW; Li GQ; Li YS; Qiu XG
    Sci Rep; 2021 Aug; 11(1):16239. PubMed ID: 34376710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
    Dong W; Du D; Huang H
    Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346.
    Li X; Yang S; Zhao C; Yang J; Li C; Shen W; Hu H; Zhang W; Yang S
    Endocr J; 2021 Aug; 68(8):1011-1025. PubMed ID: 34092745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients.
    Lei Q; Wang Y; Li J; Wang S; Hu Y; Duan L; Huo Y; Wu Y; Liu H
    Aging (Albany NY); 2023 May; 15(9):3572-3585. PubMed ID: 37155149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification a unique disulfidptosis classification regarding prognosis and immune landscapes in thyroid carcinoma and providing therapeutic strategies.
    Feng Z; Zhao Q; Ding Y; Xu Y; Sun X; Chen Q; Zhang Y; Miao J; Zhu J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11157-11170. PubMed ID: 37347261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic and immune significance of PLBD1 in pan-cancer and its roles in proliferation and invasion of glioma.
    Wei M; Zhou G; Chen L; Zhang Y; Ma W; Gao L; Gao G
    J Cancer; 2024; 15(12):3857-3872. PubMed ID: 38911364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TTN mutations predict a poor prognosis in patients with thyroid cancer.
    Han X; Chen J; Wang J; Xu J; Liu Y
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of BHLHE40 promotes immune infiltration and tumor progression in thyroid cancer.
    Gong Q; Li H
    Chin J Physiol; 2023; 66(3):153-161. PubMed ID: 37026212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive pan-cancer analysis revealing
    Li X; Wang Y; Li X; Kong L; Díez JJ; Wang H; Zhang D
    Gland Surg; 2024 Jun; 13(6):999-1015. PubMed ID: 39015705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the molecular features, relevant immune and clinical characteristics of
    Hou X; Chen C; Lan X; He X
    Front Immunol; 2022; 13():975787. PubMed ID: 36159823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Validation of an Immune-Related lncRNA Prognosis Model for Thyroid Cancer.
    Li Z; Wang H; Deng X; Zhang J; Wang L; Tang W; You W; Nian W
    Comb Chem High Throughput Screen; 2022; 25(13):2217-2227. PubMed ID: 35209814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.